Proton Therapy System for Cancer Identification Approved
The Food and Drug Administration has approved a new scanning technology developed by Hitachi for use with the company’s PROBEAT Proton Beam Therapy System. News of the approval was printed by Boston.com
The spot scanning technology system integrated with the Probeat uses a narrow beam. This system allows for perfected positioning during tumor treatment. Delivery of treatment to the most localized location possible reduces the likelihood that surrounding tissue will receive therapy and be damaged.
The treatment system, the Probeat Proton Beam Therapy System, was originally approved by the FDA in March of 2006. Proton Therapy is different than radiation therapy. This approach allows treating patients with a higher dose of radiation while simultaneously minimizing damage to surrounding healthy tissues.